SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-017718
Filing Date
2020-08-13
Accepted
2020-08-13 06:06:05
Documents
64
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcda20200630_10q.htm 10-Q 665715
2 EXHIBIT 31.1 ex_198131.htm EX-31.1 11410
3 EXHIBIT 31.2 ex_198132.htm EX-31.2 12312
4 EXHIBIT 32.1 ex_198133.htm EX-32.1 4818
5 EXHIBIT 32.2 ex_198134.htm EX-32.2 4811
  Complete submission text file 0001437749-20-017718.txt   3549453

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bcda-20200630.xml EX-101.INS 591540
7 XBRL TAXONOMY EXTENSION SCHEMA bcda-20200630.xsd EX-101.SCH 46776
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcda-20200630_cal.xml EX-101.CAL 34331
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20200630_def.xml EX-101.DEF 286608
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20200630_lab.xml EX-101.LAB 254446
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20200630_pre.xml EX-101.PRE 314036
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38999 | Film No.: 201097075
SIC: 2836 Biological Products, (No Diagnostic Substances)